Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -17.26x is 39% above its 5-year average of -28.51x, near the high end of its 5-year range (-123.38x–2.85x).
69.01% above its 12-month average of -55.69x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -45.74x.
INTEREST COVERAGE RATIO
-17.26x
INTEREST COVERAGE RATIO AVG TTM
-55.69x
INTEREST COVERAGE RATIO AVG 3Y
-25.63x
INTEREST COVERAGE RATIO AVG 5Y
-28.51x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+69.01%
CURRENT VS 3Y AVG
+32.67%
CURRENT VS 5Y AVG
+39.45%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-170.75%
vs the sector median at left
Healthcare Triangle, Inc.
Market Cap
$8.33M
Interest Coverage Ratio
-17.26x
TTM Avg
-55.69x
3Y Avg
-25.63x
5Y Avg
-28.51x
Market Cap
$8.14M
Interest Coverage Ratio
-11.17x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.05M
Interest Coverage Ratio
-17.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.04M
Interest Coverage Ratio
-97.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.87M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.82M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.75M
Interest Coverage Ratio
-1049.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.67M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | $8.33M | -17.26x | -55.69x | -25.63x | -28.51x |
| HeartSciences Inc. (HSCS)vs › | $8.14M | -11.17x | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.05M | -17.73x | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $8.04M | -97.81x | N/A | N/A | N/A |
| Traws Pharma, Inc. (TRAW)vs › | $7.92M | N/A | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.87M | N/A | N/A | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.82M | N/A | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | -1049.68x | N/A | N/A | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.67M | N/A | N/A | N/A | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | -185.05x | N/A | N/A | N/A |
Interest Coverage
-17.3x
Debt/Equity
0.26
Current Ratio
0.60
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -45.74x |
| 2026-03-31 | -42.62x |
| 2025-12-31 | -44.41x |
| 2025-09-30 | -80.97x |
| 2025-06-30 | -64.71x |
| 2025-03-31 | -3.38x |
| 2024-12-31 | -1.00x |
| 2024-09-30 | -14.59x |
| 2024-06-30 | -10.52x |
| 2024-03-31 | -11.46x |
| 2023-12-31 | -1.57x |
| 2023-09-30 | -3.67x |
| 2023-06-30 | -8.58x |
| 2023-03-31 | -51.76x |
| 2022-12-31 | -75.94x |
| 2022-09-30 | -40.85x |
| 2022-06-30 | -24.71x |
| 2022-03-31 | -123.38x |
| 2021-12-31 | -38.44x |
| 2021-09-30 | -8.02x |
| 2021-06-30 | 2.85x |
| 2020-09-30 | 164.78x |
| 2020-06-30 | 24.84x |
